开放政府环境下医药公司与医生之间的价值转移

doi:10.11959/j.issn.2096-0271.2017034

Abstract

Abstract:

Potential conflicts of interest arising from the transfer of value between pharmaceutical industry and physicians could significantly affect clinical care,research findings and physician decision-making.To enhance the transparency of the transfer of value between pharmaceutical industry and physicians,the open payments program of USA and disclosure UK datasets from four aspects:data resources,open status,type of transfer of value and policy guarantee were introduced.In addition,the international research advances based on the datasets were also reviewed.At last,the characteristics and existing problems of the datasets were discussed.The inspiration for China was proposed.

Key words: data sharing, pharmaceutical industry, physician, transfer of value

CLC Number:

G203

Xu NA, Haihong GUO, Jiao LI. Transfer of value from pharmaceutical industry to physicians in open government survey[J]. Big Data Research, 2017, 3(3): 103-111.

Figures/Tables 6

References 19

[1]	LO B , FIELD M J . Conflict of interest in medical research,education,and practice[M]. Washington,DC: National Academies PressPress, 2009.
[2]	SLAUGJTER M S , ROGERS J G , MILANO C A ,et al. Advanced heart failure treated with continuous-flow left ventricular assist device[J]. New England Journal of Medicine, 2009,361(23): 2241-2251.
[3]	CARLAT D . Exploring the link between industry payments to doctors and prescribing habits[J]. BMJ, 2014,349g6651.
[4]	CHANG J S . The physician payments sunshine act:data evaluation regarding payments to ophthalmologists[J]. Ophthalmology, 2015,122(4): 656-661.
[5]	AHMED R , LOPEZ J , BAE S ,et al. Where the sun shines:industry’s payments to plastic surgeons[J]. Plastic and Reconstructive Surgery, 2015,136(4 Suppl): 58.
[6]	ROHRICH R J . The process of publishing industry-affiliated articles in plastic and reconstructive surgery[J]. Plastic and Reconstructive Surgery, 2014,133(3): 757-760.
[7]	LISTED N . Doctors and pharma in China[J]. Lancet, 2013,382(9887): 102.
[8]	ROSS J S , LACKNER J E , LURIE P ,et al. Pharmaceutical company payments to physicians:early experiences with disclosure laws in vermont and minnesota[J]. JAMA, 2007,297: 1216-1223.
[9]	AGRAWAL S , BROWN D . The physician payments sunshine act--two years of the open payments program[J]. New England Journal of Medicine, 2016,374(10): 906-909.
[10]	USGA Office . Medicare,Medicaid,children’s health insurance programs;transparency reports and reporting of physician ownership or investment interests[J]. Federal Register, 2013,78(27): 9457.
[11]	ROSENTHAL M B , MELLO M M . Sunlight as disinfectant--new rules on disclosure of industry payments to physicians[J]. New England Journal of Medicine, 2013,368(22): 2052-2054.
[12]	AGRAWAL S , BRENNAN N , BUDETTI P . The sunshine act--effects on physicians[J]. New England Journal of Medicine, 2013,368(22): 2054-2057.
[13]	HAWKES N . Doctors getting biggest payments from drug companies don't declare them on new website[J]. BMJ, 2016,354:i3679.
[14]	PERLIS R H , PERLIS C S . Physician payments from industry are associated with greater medicare part D prescribing costs[J]. Plos One, 2016,11(5):e0155474.
[15]	LOPEZ J , AHMED R , BAE S ,et al. A new culture of transparency:industry payments to orthopedic surgeons[J]. Orthopedics, 2016,39(6): e1058-e1062.
[16]	AHMED R , BAE S , HICKS C W ,et al. Here comes the sunshine:industry’s payments to cardiothoracic surgeons[J]. Annals of Thoracic Surgery, 2016,103(2): 567.
[17]	FLEISCHMAN W , AGRAWAL S , KING M ,et al. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing:cross sectional ecological study[J]. BMJ, 2016,354:i4189.
[18]	YEH J S , FRANKLIN J M , AVORN J ,et al. Association of industry payments to physicians with the prescribing of brandname statins in massachusetts[J]. Jama Internal Medicine, 2016,176(6): 763.
[19]	ADLINGTON K , GODLEE F . Disclosure UK:transparency should no longer be an optional extra[J]. BMJ, 2016,354: 3730.

Metrics

Recommended 0

No Suggested Reading articles found!

医生识别码	医生所在主要商业街地址	医生所在城市	医生专业	医药公司识别码	资助费用/美元	价值转移类型
292757	155 Crystal Beach DR	德斯坦	矫形外科	100000005706	9 998.24	咨询费
527178	8020 Dallas ST	史密斯堡	牙科	100000000065	24.00	礼品
91436	10 Union Sq E	纽约	矫形外科	100000010751	9 992.90	旅行住宿
65688	1337 S.Lovers Lane	维塞利亚		100000011099	15 000.00	当前或预期所有权或投资利益
144912	1410 E Woodrow Wilson Ave Ste D	杰克逊	创伤骨科	100000005700	9 991.17	版权或许可

价值转移类型	范围界定
咨询费	通常根据书面协议以及特定业务需求，资助医生对特定医疗产品或治疗的咨询与专业解答费用，资助金额根据医生的经验而变化
咨询外的有偿服务	除继续教育以外的演讲、培训和教育工作费用的资助
酬金	类似于咨询费，但一般特指一次性或短期活动，通常用于禁止定制价格的服务
礼品	通常包括提供给医生或教学医院的不同于其他类别的任何东西
娱乐	参加收费的娱乐、文化、体育或其他活动
教育	通常包括涉及传授、获取特定知识或技能的课程、活动、计划、事件的资助或价值转移，此类别可以包括教科书和医学杂志文章等
科研	针对不同类型研究活动的资助，包括招募患者进行新药或器械临床测试的研究
慈善捐款	对具有免税资格的组织进行的任何资助或价值转移
版权或许可	基于使用医生知识产权进行产品销售的特许使用金或其他付款
当前或预期所有权或投资利益	目前由医生和教学医院持有的所有权或投资利益以及医生和教学医院预期的所有权利益或投资
赠款	为支持特定的事业或活动而给医生或教学医院的资助

医生/组织姓名	医生/组织所在主要商业街地址	医生/组织所在城市	医生专业	医药公司	资助费用/英镑	价值转移类型
Muhammad Abbasi	Southgate	庞蒂弗拉克特	综合内科	辉瑞公司	427.73	旅行住宿
Stockport CCG	Heaton Lane	斯托克波特		阿斯利康公司	55 584.0	联合工作
ZahirAbbasi	Moorgate Road	罗瑟勒姆	泌尿外科	葛兰素史克公司	600.0	费用
Mohammad Abbasi	Newton Road	托基	眼科	诺华制药公司	427.14	注册费
Alireza Abdolrasouli	Fulham Palace Road	伦敦	微生物免疫科	吉利德公司	452.28	服务或咨询合同中约定的相关费用

价值转移类型	范围界定
联合工作	为了联合发展和以患者为中心的项目实施，而对医药公司和英国国家医疗服务系统的技能、经验和资源的安排整理
费用	资助给医疗保健专业人员和相关卫生决策者的费用以及代表他们资助给其雇主的费用
服务或咨询合同中约定的相关费用	此类型通常包括演讲费、参与咨询委员会和提供培训的资助
与HCO或第三方的赞助协议	关于医疗保健组织或第三方组织的会议费用的资助，包括赞助医疗保健专业人员的会议注册费、住宿和旅行费用
向HCO的捐赠和赠款	向医疗保健组织提供的捐赠、赠款和实物福利

Transfer of value from pharmaceutical industry to physicians in open government survey

RichHTML

PDF下载

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 19

Related Articles 15

Metrics

Recommended 0

[1]	Yue WANG. Research on key issues and strategies of China’s government data sharing flow pipeline construction based on process perspective [J]. Big Data Research, 2023, 9(3): 29-38.
[2]	Yi LI, Jinsong WANG, Hongwei ZHANG. Research on privacy data security sharing scheme based on blockchain and function encryption [J]. Big Data Research, 2022, 8(5): 33-44.
[3]	Fei GAO, Guomin ZHOU, Rui MAN. Centralization of agricultural scientific data management model based on life cycle theory [J]. Big Data Research, 2022, 8(1): 24-36.
[4]	Yifan CHEN, Shen YAN, Yachao YANG, Lin HU, Jingchao FAN, Xianghe ZHANG, Uguomin ZHO. Agricultural science data sharing protocol in China [J]. Big Data Research, 2022, 8(1): 46-59.
[5]	Miao SUN, Zike WANG, Xin TONG, Yu FU, Yi WANG, Linchong KANG, Xiaoyi JIANG. Status of classical marine environmental observing data products application and enlightenment to China [J]. Big Data Research, 2022, 8(1): 73-83.
[6]	Lin YANG, Wei WANG, Ji ZHU, Mingzheng WANG. Research and practice on education data standard system for data sharing [J]. Big Data Research, 2020, 6(6): 3-13.
[7]	Yansong LIU, Qi XIA, Zhu LI, Hu XIA, Xiaosong ZHANG, Jianbin GAO. Research on secure data sharing system based on blockchain [J]. Big Data Research, 2020, 6(5): 92-105.
[8]	Zhao ZHANG, Jixin TIAN, Cheqing JIN. On-chain witness and off-chain transmission trustworthy data sharing platform [J]. Big Data Research, 2020, 6(5): 106-117.
[9]	. Sharing,integration and fusion of governmentgovernance big data [J]. Big Data Research, 2020, 6(2): 27-40.
[10]	Yangyong ZHU, Yun XIONG, Zhicheng LIAO, Yazhen YE. Self-governing openness of data [J]. Big Data Research, 2018, 4(2): 3-13.
[11]	Yi SHEN, Xu YAO, Yangyong ZHU. General design of self-governing openness of data and the exploring of the new mode of governance [J]. Big Data Research, 2018, 4(2): 14-20.
[12]	Yun XIONG, Yangyong ZHU. Data box:a novel data model for self-governing openness of data [J]. Big Data Research, 2018, 4(2): 21-30.
[13]	Xinhai LIU, Han HAN, Wei DING, Ti WANG. Application of telecommunication big data in credit risk management [J]. Big Data Research, 2017, 3(3): 94-102.
[14]	Jianhui LI, Yuanchun ZHOU, Lianglin HU, Feng LIU, Yanhua ZHU, Zhihong SHEN, Zhangsheng WU, Yang ZHANG. Scientific data cloud construction and service of Chinese Academy of Sciences [J]. Big Data Research, 2016, 2(6): 3-13.
[15]	HANG Z, LI Lili, . Research data openness:development,models and new exploration [J]. Big Data Research, 2016, 2(6): 25-33.